TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22240272

Group type: EXPERIMENTAL
Intervention: Gepirone-ER
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 181
Study: 19632524

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 500

Group type: COMPARATOR
Intervention: Pravastatin
Number of subjects: 500
Study: 17502757

Group type: EXPERIMENTAL
Intervention: EnSite NavX-guided ablation (group II, n=38)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Fluoroscopy-guided ablation (group I, n=35)
Number of subjects: 73
Study: 15175957

Group type: EXPERIMENTAL
Intervention: Postoperative two drug chemotherapy for stage I in intermediate risk or anaplasia reduced from 3 courses to 1 course
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Post-chemotherapy blastemal predominant subtype
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Focal anaplasia
Number of subjects: 637
Study: 11597384

Group type: EXPERIMENTAL
Intervention: Oral care protocol intervention (tooth brushing, 0.2% chlorhexidine mouth rinse, 0.9% saline rinse)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no oral care protocol)
Number of subjects: 42
Study: 9589759

Group type: EXPERIMENTAL
Intervention: Assertive community treatment (ACT)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Standard case management
Number of subjects: 223
Study: 7818835

Group type: EXPERIMENTAL
Intervention: Captopril (ACE inhibitor)
Number of subjects: 0
Study: 2977328

Group type: EXPERIMENTAL
Intervention: Autogenic training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no behavioral intervention)
Number of subjects: 90
Study: 29127458

Group type: EXPERIMENTAL
Intervention: BI 655064 (IV; 0.2-120 mg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: BI 655064 (SC; 40-120 mg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: BI 655064 (IV; doses ≥ 20 mg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: BI 655064 (SC; 120 mg)
Number of subjects: 72
Study: 26443242

Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 4133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4133
Study: 24746358

Group type: EXPERIMENTAL
Intervention: Topical natamycin
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Voriconazole
Number of subjects: 221

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 221
Study: 22688136

Group type: EXPERIMENTAL
Intervention: Chemoradiation
Number of subjects: 24
Study: 20420756

Group type: EXPERIMENTAL
Intervention: Convenience drink supplemented with n‐3 fatty acids (200 mg EPA and 300 mg DHA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (1.1 g linoleic acid from maize oil)
Number of subjects: 50
Study: 17705160

Group type: EXPERIMENTAL
Intervention: Active Neuromuscular Electrical Stimulation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo Neuromuscular Electrical Stimulation
Number of subjects: 74
Study: 15970792

Group type: EXPERIMENTAL
Intervention: FSH dose of 150 U/day (Group I, Ser/Ser)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: FSH dose of 225 U/day (Group II, Ser/Ser)
Number of subjects: 93

Group type: COMPARATOR
Intervention: FSH dose of 150 U/day (Group III, Asn/Asn)
Number of subjects: 93
Study: 15600135

Group type: EXPERIMENTAL
Intervention: Morning bright light
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evening bright light
Number of subjects: 0
Study: 10589812

Group type: EXPERIMENTAL
Intervention: Instructional video (group V)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Instructional leaflet (group L)
Number of subjects: 26
Study: 8909623

Group type: EXPERIMENTAL
Intervention: Safe Dates Project program including a theater production, a 10-session curriculum, and a poster contest.
Number of subjects: 1967

Group type: EXPERIMENTAL
Intervention: Safe Dates Project program
Number of subjects: 1967

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 1967
Study: 8101772

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg BID)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 3565301

Group type: EXPERIMENTAL
Intervention: Fasted MHD patients predialysis
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nonfasted MHD patients
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All MHD patients predialysis and postdialysis
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal individuals
Number of subjects: 24
Study: 28844717

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24IU)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 28959471

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 0
Study: 26307539

Group type: EXPERIMENTAL
Intervention: FamHFcare intervention
Number of subjects: 20
Study: 23047595

Group type: EXPERIMENTAL
Intervention: Increased dose telmisartan (80 mg/day) combined with trichlormethiazide (1 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Triple combination of telmisartan (40 mg/day), trichlormethiazide (1 mg/day), and amlodipine (5 mg/day)
Number of subjects: 40
Study: 22051143

Group type: EXPERIMENTAL
Intervention: Preventive (swallowing) exercise program (PREP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study: 19641331

Group type: EXPERIMENTAL
Intervention: First-ever stroke patients
Number of subjects: 2051
Study: 16484911

Group type: EXPERIMENTAL
Intervention: Standard diet supplemented with eicosapentaenoic acid (EPA) and gamma-linolenic acid (GLA) for 14 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard diet
Number of subjects: 100
Study: 12628899

Group type: EXPERIMENTAL
Intervention: Distraction therapy with nature sights and sounds (nature scene murals and nature sounds tape)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no nature sights or sounds)
Number of subjects: 80
Study: 10669333

Group type: EXPERIMENTAL
Intervention: Potent antiretroviral therapy (protease inhibitor‐containing)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Baseline characteristics (virus load and CD4+ T cell count)
Number of subjects: 11
Study: 8951263

Group type: EXPERIMENTAL
Intervention: Milk-based cereal diet (n = 60)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Milk-free cereal diet (n = 56)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 116
Study: 2023702

Group type: EXPERIMENTAL
Intervention: High-dose prochlorperazine infusion and dexamethasone (HDPD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: High-dose metoclopramide and dexamethasone (HDMD)
Number of subjects: 20
Study: 7067184

Group type: EXPERIMENTAL
Intervention: Sustained release metoprolol (200 mg durule)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional metoprolol (100 mg twice daily)
Number of subjects: 10
Study: 31810462

Group type: EXPERIMENTAL
Intervention: Combined functional resistance and endurance exercises 60 min, 3 times per week for 12 weeks
Number of subjects: 64
Study: 28498078

Group type: EXPERIMENTAL
Intervention: Patient self-administration of Kinetic Oscillatory Stimulation (KOS) catheter
Number of subjects: 29

Group type: COMPARATOR
Intervention: Insertion of KOS catheter by physician with helmet fixation
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Patient self-administration of KOS catheter
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Total study population (n = 26)
Number of subjects: 29
Study: 25296740

Group type: EXPERIMENTAL
Intervention: Cryo-chamber therapy at -67 °C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham cryo-chamber therapy at -5 °C
Number of subjects: 0
Study: 23819221

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (1 Hz/50 Hz) for 30 min once daily for 14 days
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Naloxone (0.4 mg/kg for first 3 days, 0.2 mg/kg for 7 days, 0.1 mg/kg afterwards)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine medication (mild hypothermia, dehydration medicines, hormonal therapy, vascular dilation, cerebral nutrition, anti-inflammation)
Number of subjects: 90
Study: 21764840

Group type: COMPARATOR
Intervention: Control diet containing 70% corn and 0% SH
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diet with 15% SH
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diet with 30% SH
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diet with 45% SH
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diet with SH
Number of subjects: 16
Study: 19167143

Group type: EXPERIMENTAL
Intervention: Barriers to research participation rated by participants
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Gender and gender by age interactions
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Baseline barriers
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Inadequate social support, unstable job, and the use of alcohol and drugs
Number of subjects: 285
Study: 16622139

Group type: COMPARATOR
Intervention: Amalgam
Number of subjects: 534

Group type: COMPARATOR
Intervention: Resin composite
Number of subjects: 534
Study: 15636250

Group type: EXPERIMENTAL
Intervention: Trypan blue staining during surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: No trypan blue staining during surgery
Number of subjects: 0
Study: 11327549

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) treatment
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (saline) treatment
Number of subjects: 41
Study: 9121502

Group type: EXPERIMENTAL
Intervention: Anti-GM1 antibodies
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Anti-GQ1b antibodies
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Patients with anti-GM1 antibodies
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Patients with anti-GQ1b antibodies
Number of subjects: 124
Study: 8002061

Group type: EXPERIMENTAL
Intervention: Morning dose of hydrocortisone (20 mg/m2 daily)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Night dose of hydrocortisone (20 mg/m2 daily)
Number of subjects: 13
Study: 3042841

Group type: EXPERIMENTAL
Intervention: Naloxone HCl 2.0 mg/kg IV bolus
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Naloxone HCl 0.1 mg/kg IV bolus
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Naloxone HCl 5 micrograms/kg IV bolus
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30385649

Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes (0.4 mg nicotine/g tobacco)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Brand (UB) cigarettes
Number of subjects: 0
Study: 27782128

Group type: EXPERIMENTAL
Intervention: FEP group
Number of subjects: 272

Group type: COMPARATOR
Intervention: FEP, MDD, and PTSD groups
Number of subjects: 272
Study: 25402372

Group type: EXPERIMENTAL
Intervention: metformin 1700 mg/d plus vildagliptin 100 mg/d
Number of subjects: 64

Group type: COMPARATOR
Intervention: metformin 1700 mg/d
Number of subjects: 64
Study: 23358831

Group type: EXPERIMENTAL
Intervention: Electrical biochip technology for MMP 7 analysis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard ELISA technique for MMP 7 analysis
Number of subjects: 30
Study: 21600723

Group type: EXPERIMENTAL
Intervention: High patient-centered communication (PCC) vignettes
Number of subjects: 248

Group type: COMPARATOR
Intervention: Low patient-centered communication (PCC) vignettes
Number of subjects: 248
Study: 18462835

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 16527024

Group type: EXPERIMENTAL
Intervention: Sutured tracheostomy site
Number of subjects: 75

Group type: COMPARATOR
Intervention: Nonsutured tracheostomy site
Number of subjects: 75
Study: 12930192

Group type: EXPERIMENTAL
Intervention: A-CAL
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: A-WT
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study: 10987449

Group type: EXPERIMENTAL
Intervention: Behavioral interventions
Number of subjects: 2879
Study: 9364693

Group type: EXPERIMENTAL
Intervention: Passive-active hepatitis B immunization
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Starting active immunization at birth
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Starting active immunization at 3 months of age
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Maternal HBV DNA < 150 pg ml-1
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Maternal HBV DNA > 150 pg ml-1
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Concomitant DKTP vaccination
Number of subjects: 705
Study: 1551035

Group type: EXPERIMENTAL
Intervention: terfenadine 120 mg twice daily
Number of subjects: 52

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 52
Study: 3861070

Group type: EXPERIMENTAL
Intervention: Extra early physical contact (EC)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Regular contact (RC)
Number of subjects: 78
Study: 29580640

Group type: EXPERIMENTAL
Intervention: EasySix™ vaccine
Number of subjects: 284

Group type: COMPARATOR
Intervention: Pentavac SD® (DTwP‐HepB/Hib) and Imovax Polio®
Number of subjects: 284
Study: 27559737

Group type: EXPERIMENTAL
Intervention: Hypertonic saline injection (pain)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Isotonic saline injection (control)
Number of subjects: 22
Study: 24688081

Group type: EXPERIMENTAL
Intervention: Benefit-finding intervention
Number of subjects: 25

Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 25
Study: 22828857

Group type: EXPERIMENTAL
Intervention: Low-dose remifentanil (0.05-0.125 μg/kg/min) and propofol (1-3 mg/kg/h)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Propofol (1-3 mg/kg/h)
Number of subjects: 12
Study: 20653166

Group type: EXPERIMENTAL
Intervention: Chinese medicine (dissolving phlegm-stasis)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Votalin and Vitamin C (control)
Number of subjects: 100
Study: 17923653

Group type: EXPERIMENTAL
Intervention: Health report card with counselling on smoking, exercise, nutrition and stress (intervention group)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Health report card with counselling (intervention group)
Number of subjects: 310
Study: 16275486

Group type: EXPERIMENTAL
Intervention: Betaxolol hydrochloride (5 mg daily for 3 weeks)
Number of subjects: 17
Study: 12175392

Group type: EXPERIMENTAL
Intervention: tolterodine 2 mg twice daily for 10 weeks
Number of subjects: 106

Group type: COMPARATOR
Intervention: oxybutynin 5 mg twice daily for 10 weeks
Number of subjects: 106
Study: 10442207

Group type: EXPERIMENTAL
Intervention: sustained release capsules containing 100 mg tramadol hydrochloride, total of 6 capsules at intervals of 12 h
Number of subjects: 24

Group type: COMPARATOR
Intervention: instant release capsules containing 50 mg tramadol hydrochloride, total of 12 capsules at intervals of 6 h
Number of subjects: 24
Study: 7598920

Group type: EXPERIMENTAL
Intervention: eltanolone 0.58 mg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: propofol 1.7 mg/kg
Number of subjects: 40
Study: 2145877

Group type: EXPERIMENTAL
Intervention: Back school plus wearing a custom molded lumbosacral orthosis
Number of subjects: 90

Group type: COMPARATOR
Intervention: Back school only
Number of subjects: 90

Group type: COMPARATOR
Intervention: True controls, no back school, no brace orthoses
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Orthoses and training-group
Number of subjects: 90
Study: 876810

Group type: EXPERIMENTAL
Intervention: Dark-adapted condition
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Intermediate-adapted condition
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Light-adapted condition
Number of subjects: 33
Study: 31129929

Group type: EXPERIMENTAL
Intervention: Remote patient management (RPM)
Number of subjects: 1538

Group type: COMPARATOR
Intervention: Not recommended for RPM (control group)
Number of subjects: 1538
Study: 29373884

Group type: EXPERIMENTAL
Intervention: Progesterone suppositories (400 mg per night) until delivery or completion of the 34th gestational week
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 26480548

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy at Shenmen (HT 7), Baihui (GV 20), Yintang (GV 29), Hegu (LI 4), Taichong (LR 3), needles retained for 20 min, treatment once a day for 2 weeks (1 session).
Number of subjects: 70

Group type: COMPARATOR
Intervention: Oral administration of trazodone, 100 mg, once a day for 2 weeks (1 session).
Number of subjects: 70
Study: 23567596

Group type: EXPERIMENTAL
Intervention: P. ginseng (100 mg/d)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Amitriptyline (25 mg/d)
Number of subjects: 38
Study: 21766893

Group type: EXPERIMENTAL
Intervention: Treatment with a greater chance of success
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Treatment with lower cost
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Treatment with shorter duration before being able to exercise free of pain
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Treatment with lower chance of side effects
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Injections as a stand-alone treatment
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 10% increase in chance of treatment success
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Exercises
Number of subjects: 58
Study: 19106150

Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 40
Study: 16900564

Group type: EXPERIMENTAL
Intervention: Autoregressive linear mixed effects model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Error structures proposed
Number of subjects: 0
Study: 15090391

Group type: EXPERIMENTAL
Intervention: Screw-in anchors (vertical sutures)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Screw-in anchors (horizontal sutures)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Bioabsorbable tacks
Number of subjects: 21
Study: 11574347

Group type: EXPERIMENTAL
Intervention: Midazolam (0.025, 0.05, and 0.1 mg/kg)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Propofol (0.25, 0.5, and 1.0 mg/kg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (healthy patients)
Number of subjects: 34
Study: 9693434

Group type: EXPERIMENTAL
Intervention: NPPV (Noninvasive Positive Pressure Ventilation)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional therapy (non-NPPV)
Number of subjects: 58
Study: 8159123

Group type: EXPERIMENTAL
Intervention: Birth centre care (EG)
Number of subjects: 1230

Group type: COMPARATOR
Intervention: Standard obstetric care (CG)
Number of subjects: 1230
Study: 2900901

Group type: EXPERIMENTAL
Intervention: FAT (5-fluorouracil, doxorubicin, triazinate)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: FAP (5-fluorouracil, doxorubicin, cisplatin)
Number of subjects: 100

Group type: COMPARATOR
Intervention: FAMe (5-fluorouracil, doxorubicin, semustine)
Number of subjects: 100
Study: 31932932

Group type: EXPERIMENTAL
Intervention: Postoperative laparoscopic-guided TAP block (TAP-lap)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control (no TAP block)
Number of subjects: 140
Study: 29688873

Group type: EXPERIMENTAL
Intervention: Dialectical Behavioural Therapy (DBT) for 12 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 48
Study: 27334418

Group type: EXPERIMENTAL
Intervention: Wireless self-monitoring program (n=52)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard disease management program (n=43)
Number of subjects: 95
Study: 24061274

Group type: EXPERIMENTAL
Intervention: Trivalent seasonal influenza vaccine (TIV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23663510

Group type: EXPERIMENTAL
Intervention: Sequential bilateral rTMS
Number of subjects: 179

Group type: COMPARATOR
Intervention: Right-sided unilateral rTMS
Number of subjects: 179
Study: 20180109

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (2 microg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sterile water (placebo)
Number of subjects: 0
Study: 18575851

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg orally
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15793053

Group type: EXPERIMENTAL
Intervention: Ultrasonic Harmonic Scalpel
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard method (hemostatic clips, scissors, minimal electrocautery)
Number of subjects: 100
Study: 12218529

Group type: EXPERIMENTAL
Intervention: Mivacurium infusion (0.2 mg/kg bolus followed by 3, 5, or 7 microg/kg/min infusion)
Number of subjects: 8
Study: 10333832

Group type: EXPERIMENTAL
Intervention: Therapeutic pressure (50 mm Hg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo pressure (15 mm Hg)
Number of subjects: 15
Study: 8599955

Group type: EXPERIMENTAL
Intervention: 99mTc-exametazime labelled leucocytes
Number of subjects: 23

Group type: COMPARATOR
Intervention: 99mTc-labelled antibodies against granulocyte non-specific cross-reacting antigen-95
Number of subjects: 23
Study: 1924659

Group type: EXPERIMENTAL
Intervention: mianserin (30 mg to 150 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: amitriptyline (60 mg to 300 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: placebo (1 to 5 capsules at bedtime)
Number of subjects: 150
Study: 7051248

Group type: EXPERIMENTAL
Intervention: Parenteral trimethoprim‐sulfamethoxazole and carbenicillin (TMP‐SMZ‐C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gentamicin and carbenicillin (G‐C)
Number of subjects: 0
Study: 31531150

Group type: EXPERIMENTAL
Intervention: IgG elimination diet
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diet combined with probiotics
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study: 29398152

Group type: EXPERIMENTAL
Intervention: Daily online CBCT IGRT (7 mm margins to PTV)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Weekly offline portal imaging (15 mm margins to PTV)
Number of subjects: 257
Study: 26636178

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93